GlassScriptPhysician profile
Beka Bakhtadze
NPI 1659754901
$9,559.51
in general payments reported to CMS, 2019-2025
18 companies · $3,416 in 2025
The $3,416 reported for 2025 was more than what 97% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $77.73 · 2023: $2,831 · 2024: $3,235 · 2025: $3,416.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,593 · Travel and Lodging: $3,194 · Education: $695.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,593.23 |
| Travel and Lodging | $3,193.76 |
| Education | $694.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,256.69 | 2022-2025 | Optis, Dragonfly Opstar, Diamondback Coronary |
| Edwards Lifesciences Corporation | $1,929.08 | 2023-2025 | Sapien 3 Ultra Resilia, Pascal, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| W. L. Gore & Associates, INC. | $1,747.48 | 2023-2025 | Gore Cardioform Septal Occluder, Gore Cardioform Asd Occluder |
| Medtronic, INC. | $974.17 | 2023-2025 | Harmony, Corevalve Evolut R, Onyx Frontier |
| Penumbra, INC. | $356.04 | 2023-2024 | Indigo System, Penumbra System |
| Cardiovascular Systems INC. | $276.11 | 2023 | Diamondback Coronary |
| Heartflow, INC. | $256.22 | 2023 | Ffrct |
| Abiomed | $181.40 | 2025 | |
| Canon Medical Systems USA, INC. | $143.24 | 2023 | Interventional Angiography System |
| Cordis US Corp. | $102.06 | 2023 | Mynx Control |
| Cathworks, INC. | $84.12 | 2023 | Ffrangio |
| Biotronik INC. | $68.68 | 2023-2024 | Orsiro Mission, Recross, Pk Papyrus |
| Cardiva Medical, INC. | $64.23 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade 6/7f Vcs |
| Verge Medical, INC. | $38.07 | 2023 | |
| Philips North America LLC | $32.00 | 2025 | Labosys |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $24.97 | 2023 | |
| Terumo Medical Corporation | $14.91 | 2024 | Metacross Otw |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $10.04 | 2024 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beka Bakhtadze listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.